MRP ₹860
(Inclusive of all Taxes)
₹116.1 Cashback (13%)
Extra 15% Off with Bank Offers
coupon
Prescription drugWhats That
Composition :
CARBOPLATIN-150MG
Manufacturer/Marketer :
BDR Pharmaceuticals Internationals Pvt Ltd
Consume Type :
PARENTERAL
Return Policy :
Not Returnable
Expires on or after :
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Alcohol
Caution
You are recommended to avoid alcohol consumption while taking Innocar 150 mg Injection. It could lead to avoiding unpleasant side effects.
Pregnancy
Unsafe
Innocar 150 mg Injection should not be used during pregnancy because it causes harm to the fetus (newborn baby). Both women of childbearing potential and men must use an effective contraception method while taking Innocar 150 mg Injection and at least six months afterwards. Please consult your doctor about any concerns regarding this.
Breast Feeding
Unsafe
Innocar 150 mg Injection should not be taken during breastfeeding as it passes into the breastmilk and may harm the nursing baby. It is contraindicated in breastfeeding mothers. Please consult your doctor about any concerns regarding this.
Driving
Caution
Innocar 150 mg Injection may affect your reactions and your ability to drive. Possible side effects of chemotherapy with Innocar 150 mg Injection may occur, such as nausea and vomiting. If you are affected by these side effects, you should not drive and/or operate machines that require you to be alert.
Liver
Caution
If you have had a history or evidence of any liver-related diseases, please consult the doctor before taking Innocar 150 mg Injection. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
Kidney
Caution
If you have had a history or evidence of any kidney-related diseases, please consult the doctor before taking Innocar 150 mg Injection. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
Children
Unsafe
Efficacy and safety have not been established. Please consult your doctor. Your doctor will weigh the benefits and potential risks before prescribing them.
Product Substitutes
Drug-Drug Interactions
Critical
Severe
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Innocar 150 mg Injection 15 ml:
Co-administration of Sorafenib with Innocar 150 mg Injection 15 ml can increase the risk or severity of serious side effects.
How to manage the interaction:
Taking Sorafenib with Innocar 150 mg Injection 15 ml together is not recommended as it can cause an interaction, consult a doctor before taking it. However if you experience any unusual symptoms, consult the doctor. Do not stop using any medications without consulting a doctor.
Co-administration of Sorafenib with Innocar 150 mg Injection 15 ml can increase the risk or severity of serious side effects.
How to manage the interaction:
Taking Sorafenib with Innocar 150 mg Injection 15 ml together is not recommended as it can cause an interaction, consult a doctor before taking it. However if you experience any unusual symptoms, consult the doctor. Do not stop using any medications without consulting a doctor.
Severe
How does the drug interact with Innocar 150 mg Injection 15 ml:
Taking Innocar 150 mg Injection 15 ml with etanercept may increase the risk of serious infections.
How to manage the interaction:
Co-administration of Innocar 150 mg Injection 15 ml and etanercept can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience fever, chills, diarrhea, sore throat, muscular pains, shortness of breath, blood in phlegm (mucous secretion), red or irritated skin, body sores, or discomfort or burning during urination, consult a doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Innocar 150 mg Injection 15 ml with etanercept may increase the risk of serious infections.
How to manage the interaction:
Co-administration of Innocar 150 mg Injection 15 ml and etanercept can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience fever, chills, diarrhea, sore throat, muscular pains, shortness of breath, blood in phlegm (mucous secretion), red or irritated skin, body sores, or discomfort or burning during urination, consult a doctor immediately. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Innocar 150 mg Injection 15 ml:
Using Adalimumab with Innocar 150 mg Injection 15 ml can increase the risk of developing serious infections.
How to manage the interaction:
Although taking Innocar 150 mg Injection 15 ml and Adalimumab together can cause an interaction, it can be taken if your doctor has suggested it. However, if you experience fever, chills, diarrhea, sore throat, muscle pains, breathing difficulty, blood in your coughing fluid, weight loss, red or irritated skin, body sores, and discomfort or burning sensation when you urinate, consult a doctor. Do not stop using any medications without a doctor's advice.
Using Adalimumab with Innocar 150 mg Injection 15 ml can increase the risk of developing serious infections.
How to manage the interaction:
Although taking Innocar 150 mg Injection 15 ml and Adalimumab together can cause an interaction, it can be taken if your doctor has suggested it. However, if you experience fever, chills, diarrhea, sore throat, muscle pains, breathing difficulty, blood in your coughing fluid, weight loss, red or irritated skin, body sores, and discomfort or burning sensation when you urinate, consult a doctor. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Innocar 150 mg Injection 15 ml:
Taking Infliximab with Innocar 150 mg Injection 15 ml can increase the risk or severity of developing serious infections.
How to manage the interaction:
Co-administration of Infliximab with Innocar 150 mg Injection 15 ml can result in an interaction, but it can be taken if your doctor has advised it. If you have any of these symptoms like fever, chills, diarrhoea, sore throat, muscle pain, difficulty breathing, pain or burning when you pee, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
Taking Infliximab with Innocar 150 mg Injection 15 ml can increase the risk or severity of developing serious infections.
How to manage the interaction:
Co-administration of Infliximab with Innocar 150 mg Injection 15 ml can result in an interaction, but it can be taken if your doctor has advised it. If you have any of these symptoms like fever, chills, diarrhoea, sore throat, muscle pain, difficulty breathing, pain or burning when you pee, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Innocar 150 mg Injection 15 ml:
Taking cidofovir with Innocar 150 mg Injection 15 ml can increase the risk of kidney problems.
How to manage the interaction:
Although taking Innocar 150 mg Injection 15 ml and cidofovir together can possibly cause an interaction, it can be taken if your doctor has suggested it. However, if you experience loss of hunger, increased or decreased urination, swelling, shortness of breath, bone pain, muscle cramps, irregular heart rhythm, consult a doctor immediately. It is advised to wait at least for 7 days after stopping Innocar 150 mg Injection 15 ml, before taking Cidofovir. Do not stop using any medications without talking to a doctor.
Taking cidofovir with Innocar 150 mg Injection 15 ml can increase the risk of kidney problems.
How to manage the interaction:
Although taking Innocar 150 mg Injection 15 ml and cidofovir together can possibly cause an interaction, it can be taken if your doctor has suggested it. However, if you experience loss of hunger, increased or decreased urination, swelling, shortness of breath, bone pain, muscle cramps, irregular heart rhythm, consult a doctor immediately. It is advised to wait at least for 7 days after stopping Innocar 150 mg Injection 15 ml, before taking Cidofovir. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with Innocar 150 mg Injection 15 ml:
Taking Innocar 150 mg Injection 15 ml with thalidomide can increase the risk of blood clots.
How to manage the interaction:
Co-administration of Innocar 150 mg Injection 15 ml with thalidomide can possibly result in an interaction, but it can be taken if your doctor has advised it. However, If you experience chest pain, breathing difficulty, coughing up blood, and pain, redness, or swelling in an arm or leg, sudden loss of vision, consult a doctor immediately. Do not discontinue any medications without a doctor's advice.
Taking Innocar 150 mg Injection 15 ml with thalidomide can increase the risk of blood clots.
How to manage the interaction:
Co-administration of Innocar 150 mg Injection 15 ml with thalidomide can possibly result in an interaction, but it can be taken if your doctor has advised it. However, If you experience chest pain, breathing difficulty, coughing up blood, and pain, redness, or swelling in an arm or leg, sudden loss of vision, consult a doctor immediately. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with Innocar 150 mg Injection 15 ml:
Using Innocar 150 mg Injection 15 ml with Fingolimod can increase the risk of developing serious infections.
How to manage the interaction:
Although there is a possible interaction between Innocar 150 mg Injection 15 ml and Fingolimod, you can take these medicines together if prescribed by your doctor. However, if you experience fever, chills, diarrhea, sore throat, muscle pains, breathing difficulty, blood in your coughing fluid, red or irritated skin, body sores, and discomfort or burning sensation when you urinate, consult a doctor. Do not stop using any medications without a doctor's advice.
Using Innocar 150 mg Injection 15 ml with Fingolimod can increase the risk of developing serious infections.
How to manage the interaction:
Although there is a possible interaction between Innocar 150 mg Injection 15 ml and Fingolimod, you can take these medicines together if prescribed by your doctor. However, if you experience fever, chills, diarrhea, sore throat, muscle pains, breathing difficulty, blood in your coughing fluid, red or irritated skin, body sores, and discomfort or burning sensation when you urinate, consult a doctor. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Innocar 150 mg Injection 15 ml:
Taking Innocar 150 mg Injection 15 ml with Natalizumab can increase the risk of developing serious infections. Particularly, progressive multifocal leukoencephalopathy(a rare but serious viral infection of the brain).
How to manage the interaction:
Taking Innocar 150 mg Injection 15 ml with Natalizumab together can possibly result in an interaction, but it can be taken if your doctor has advised it. However, if you experience fever, chills, diarrhea, sore throat, muscle pains, breathing difficulty, blood in your coughing fluid, red or irritated skin, body sores, and discomfort or burning sensation when you urinate, weakness on one side of the body, clumsiness of legs and hands, eye problems, confusion, or changes in thinking, memory and personality, consult a doctor. Do not stop using any medications without a doctor's advice.
Taking Innocar 150 mg Injection 15 ml with Natalizumab can increase the risk of developing serious infections. Particularly, progressive multifocal leukoencephalopathy(a rare but serious viral infection of the brain).
How to manage the interaction:
Taking Innocar 150 mg Injection 15 ml with Natalizumab together can possibly result in an interaction, but it can be taken if your doctor has advised it. However, if you experience fever, chills, diarrhea, sore throat, muscle pains, breathing difficulty, blood in your coughing fluid, red or irritated skin, body sores, and discomfort or burning sensation when you urinate, weakness on one side of the body, clumsiness of legs and hands, eye problems, confusion, or changes in thinking, memory and personality, consult a doctor. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Innocar 150 mg Injection 15 ml:
When Innocar 150 mg Injection 15 ml is used with topotecan, it may increase the risk of side effects.
How to manage the interaction:
Co-administration of Innocar 150 mg Injection 15 ml with clozapine can possibly result in an interaction, but it can be taken if your doctor has advised it. However, if you experience any unusual symptoms, consult the doctor. Do not discontinue any medications without consulting your doctor.
When Innocar 150 mg Injection 15 ml is used with topotecan, it may increase the risk of side effects.
How to manage the interaction:
Co-administration of Innocar 150 mg Injection 15 ml with clozapine can possibly result in an interaction, but it can be taken if your doctor has advised it. However, if you experience any unusual symptoms, consult the doctor. Do not discontinue any medications without consulting your doctor.
Severe
How does the drug interact with Innocar 150 mg Injection 15 ml:
Using Innocar 150 mg Injection 15 ml with Deferiprone, can increase the risk of developing serious infections.
How to manage the interaction:
There may be a possibility of interaction between Innocar 150 mg Injection 15 ml and Deferiprone, but it can be taken if prescribed by a doctor. However, if you experience fever, chills, diarrhea, sore throat, muscle pains, breathing difficulty, blood in your coughing fluid, red or irritated skin, body sores, and discomfort or burning sensation when you urinate, consult a doctor. Do not stop using any medications without a doctor's advice.
Using Innocar 150 mg Injection 15 ml with Deferiprone, can increase the risk of developing serious infections.
How to manage the interaction:
There may be a possibility of interaction between Innocar 150 mg Injection 15 ml and Deferiprone, but it can be taken if prescribed by a doctor. However, if you experience fever, chills, diarrhea, sore throat, muscle pains, breathing difficulty, blood in your coughing fluid, red or irritated skin, body sores, and discomfort or burning sensation when you urinate, consult a doctor. Do not stop using any medications without a doctor's advice.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
CARBOPLATIN-150MGOther and unspecified infectious diseases
Moderate
CARBOPLATIN-150MGOther disorders of kidney and ureter, not elsewhere classified
Moderate
Drug-Diseases Interactions
Login/Sign Up
CARBOPLATIN-150MGOther and unspecified infectious diseases
Moderate
How does the disease interact with Innocar 150 mg Injection 15 ml:
Antineoplastic drugs regularly can, to variable degrees, promote myelosuppression due to their cytotoxic effects on rapidly growing tissues.
How to manage the interaction:
If you experience any signs or symptoms suggesting infection such as fever, sore throat, or local infection during antineoplastic therapy, immediately consult your doctor. Close clinical monitoring of hematopoietic function is recommended.
Antineoplastic drugs regularly can, to variable degrees, promote myelosuppression due to their cytotoxic effects on rapidly growing tissues.
How to manage the interaction:
If you experience any signs or symptoms suggesting infection such as fever, sore throat, or local infection during antineoplastic therapy, immediately consult your doctor. Close clinical monitoring of hematopoietic function is recommended.
CARBOPLATIN-150MGOther disorders of kidney and ureter, not elsewhere classified
Moderate
How does the disease interact with Innocar 150 mg Injection 15 ml:
The kidney is the main organ used to remove Innocar 150 mg Injection 15 ml. Patients with a creatinine clearance of less than 60 mL/min had lower total body and renal clearance of Innocar 150 mg Injection 15 ml.
How to manage the interaction:
If you have any kidney related problems, do not forget to mention it to your doctor, a close monitoring is required.
The kidney is the main organ used to remove Innocar 150 mg Injection 15 ml. Patients with a creatinine clearance of less than 60 mL/min had lower total body and renal clearance of Innocar 150 mg Injection 15 ml.
How to manage the interaction:
If you have any kidney related problems, do not forget to mention it to your doctor, a close monitoring is required.
CARBOPLATIN-150MGHaemorrhage, not elsewhere classified
Mild
How does the disease interact with Innocar 150 mg Injection 15 ml:
Patients who have substantial bleeding should not use Innocar 150 mg Injection 15 ml. Both severe myelosuppression and dose-dependent thrombocytopenia are brought on by Innocar 150 mg Injection 15 ml.
How to manage the interaction:
The use of Innocar 150 mg Injection 15 ml is not advisable if you have significant bleeding. If you experience any signs or symptoms suggesting bleeding such as petechiae, purpura, epistaxis, hemoptysis, hematuria, and melena, consult your doctor. Close clinical monitoring of hematopoietic function is recommended.
Patients who have substantial bleeding should not use Innocar 150 mg Injection 15 ml. Both severe myelosuppression and dose-dependent thrombocytopenia are brought on by Innocar 150 mg Injection 15 ml.
How to manage the interaction:
The use of Innocar 150 mg Injection 15 ml is not advisable if you have significant bleeding. If you experience any signs or symptoms suggesting bleeding such as petechiae, purpura, epistaxis, hemoptysis, hematuria, and melena, consult your doctor. Close clinical monitoring of hematopoietic function is recommended.
Have a query?